
Gastric cancer is the fifth most common tumor with third mortality in the world. In recent decades, the incidence and mortality of gastric cancer have declined. However, due to the population growth in areas with high incidence and the improvement of diagnosis level in relevant areas, the prevalence...

Breast cancer is one of the most common malignancies among women. As an important therapeutic strategy, neoadjuvant systemic therapy (NST) has been widely applied in patients with locally advanced breast cancer and certain high-risk molecular subtypes [1, 2]. The primary goal of NST is to downstage the...

Prostate cancer is the second most common cancer in men worldwide, with approximately 1.9 million new cases and over 800,000 deaths annually, highlighting the urgent need for accurate early diagnosis and risk stratification [1]. In recent years, positron emission tomography/computed tomography (PET/CT)...

Lung cancer remains the leading cause of cancer-related deaths worldwide, with approximately 2.2 million new cases and 1.8 million deaths annually [1]. Despite advances in diagnostic and therapeutic approaches, significant challenges remain in early detection, accurate staging, and personalized...